-36%

est. 2Y upside i

HealthcareSeries B

Profluent is an AI-first protein design company. Founded in 2022, they develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine.

Rank

#3049

Sector

Biotechnology

Est. Liquidity

~5Y

Data Quality

Data: Low

Profluent offers a strong technological moat and a major partnership with Lilly, but the current valuation at $1B on only $3.85M revenue implies extremely high expectations.

Last updated: July 19, 2026

Bull (30%)0%

Bull case assumes Profluent achieves $80M revenue in 2 years and exits at 15x multiple ($1.2B) due to successful pipeline and IPO window. After 20% dilution, net upside is 0%.

Base (50%)-40%

Base case: $80M revenue at 10x multiple yields $800M valuation (-20% from entry). After dilution, net -40%.

Bear (20%)-80%

Bear case: revenue lags at $40M, multiple compresses to 5x ($200M). After dilution and preference stack, net -80%.

Est. time to liquidity~5.0 years

Preference Stack Risk

moderate

Funding Intensity

15%

$150M in total funding represents 15% of current $1B valuation, implying moderate preference overhang.

Dilution Risk

high

With high capital intensity and only $106M raised recently, another fundraise within 2 years is likely, potentially diluting employees by 15-25%.

Secondary Liquidity

none

No secondary market activity detected; shares are illiquid.

Other — 9 roles

View all 9 open roles at Profluent →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Profluent's data — designed to show you've done your homework.

  • 1

    “How does Profluent's protein language model differ from competitors like Generate Biomedicines or Isomorphic Labs?”

  • 2

    “What are the key milestones in the Lilly partnership and how do they impact revenue recognition?”

  • 3

    “Given the high cash burn and $1B valuation, what is your view on the need for future capital raises and the impact on employee equity?”

Community

Valuation Sentiment

Our model estimates -36% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.